Back
Radian Group Inc. 10K Form
Buy
51
RDN
Radian Group Inc.
Last Price:
$34.71
Seasonality Move:
6.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-03 | 10Q | RDN/Radian Group Inc. Quarterly |
| 2023-11-03 | 10Q | RDN/Radian Group Inc. Quarterly |
| 2023-08-04 | 10Q | RDN/Radian Group Inc. Quarterly |
| 2023-05-05 | 10Q | RDN/Radian Group Inc. Quarterly |
| 2022-11-04 | 10Q | RDN/Radian Group Inc. Quarterly |
| 2022-08-05 | 10Q | RDN/Radian Group Inc. Quarterly |
Receive RDN News And Ratings
See the #1 stock for the next 7 days that we like better than RDN
RDN Financial Statistics
Sales & Book Value
| Annual Sales: | $1.3B |
|---|---|
| Cash Flow: | $357.6M |
| Price / Cash Flow: | 32.43 |
| Annual Sales: | $34.34 |
| Price / Book: | 1.01 |
Profitability
| EPS (TTM): | 4.00510 |
|---|---|
| Net Income (TTM): | $587.4M |
| Gross Margin: | $0 |
| Return on Equity: | 12.74% |
| Return on Assets: | 6.76% |
Radian Group Inc. Earnings Forecast
Key Radian Group Inc. Financial Ratios
-
The Gross Profit Margin over the past 33 years for RDN is 0.00%.
-
The Selling, General & Administrative Expenses for RDN have been equal to 0.00% of Gross Profit Margin.
-
The Interest Expense is 17.87% of Operating Income.
-
The Net Earning history of RDN is 46.85% of Total Revenues.
-
Per Share Earnings over the last 33 years have been positive in 23 years.
Radian Group Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Financial Services |
| Sector: | Financials |
| Current Symbol: | RDN |
| CUSIP: | 750236 |
| Website: | radian.com |
Debt
| Debt-to-Equity Ratio: | 0.36 |
|---|---|
| Current Ratio: | 1.77 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 8.86 |
|---|---|
| Forward P/E Ratio: | 7.8 |
RDN Technical Analysis vs Fundamental Analysis
Buy
51
Radian Group Inc. (RDN)
is a Buy
Is Radian Group Inc. a Buy or a Sell?
-
Radian Group Inc. stock is rated a BuyThe current Radian Group Inc. [RDN] share price is $34.73. The Score for RDN is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.